The UK National Institute for Health and Care Excellence has recommended a targeted twice daily drug treatment that could help around 3000 women a year with advanced breast cancer in England and Wales ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

During a a live event, Virginia Kaklamani, MD, DSc, and participants discussed their experiences using a PI3K/AKT inhibitor ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

AstraZeneca’s (AZ) AKT inhibitor Truqap (capivasertib) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a combination treatment for advanced breast ...

Two women who had breast cancer say a new pill which helps reduce its spread is a "step in the right direction". Nina Barough ...

Roche's decision to drop the programme comes after AstraZeneca's rival AKT inhibitor capivasertib improved PFS when added to Faslodex (fulvestrant) as a second-line therapy for HR-positive ...

Capivasertib trial also positive There was further good news from AZ's oncology pipeline this morning, after the company revealed that capivasertib - vying to become the first AKT inhibitor to ...

Get Latest and Breaking News about Technology. Todays Top News Headlines about Technology, News on Mobile Devices, TVs and Laptops. News about Apple, Google, Microsoft, OPPO, Vivo, Xiaomi, Samsung, ...